Tag: Pharma News

Positive findings from the second interim analysis of the phase 2 randomised trial for BX1000 are reported by Baudax Bio.

March 28, 2023
The second preplanned interim analysis of Baudax Bio, Inc.’s phase 2 trial of BX1000 for neuromuscular blockade (NMB)…

As the Union government adds new conditions to the NPRD list, patient groups are awaiting clarification on the inclusion of rare diseases.

March 27, 2023
Patient advocacy groups are awaiting clarification on whether specific conditions will be covered by the National Policy of…

In an experimental research using the ROCK inhibitor NRL-1049 to treat cerebral cavernous malformations, Neurelis has started patient dosing.

March 27, 2023
The Rho kinase (ROCK) inhibitor NRL-1049, a potential treatment for people with cerebral cavernous malformations (CCM), a condition…

To create non-viral genetic therapies, Moderna and Generation Bio have formed a strategic partnership.

March 24, 2023
Moderna, Inc., a biotechnology company that invented messenger RNA (mRNA) therapeutics and vaccines, and Generation Bio Co., a…

Ionis’ tofersen may be given accelerated approval by the USFDA for SOD1-ALS, according to the advisory committee’s unanimous vote.

March 24, 2023
Tofersen, an investigational antisense drug for the treatment of people with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis,…

When concerns about medication resistance arise, Indian healthcare professionals and pharmaceutical businesses accelerate efforts to treat TB.

March 24, 2023
When concerns about drug resistance arise, Indian healthcare practitioners and pharmaceutical corporations step up their efforts to control…

The US FDA designates Intellia’s NTLA-2002, a regenerative medicine advanced therapy to treat hereditary angioedema.

March 23, 2023
The US Food and Drug Administration (FDA) has designated NTLA-2002 for the treatment of hereditary angioedema as a…

Draft guidelines for the management of urinary bladder cancer are published by the ICMR.

March 22, 2023
The draught consensus statement for the treatment of urinary bladder cancer has been made public by the Indian…

Registration Form


This will close in 0 seconds

WhatsApp Telegram